Literature DB >> 2668962

Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes.

C L Sidman1, J D Marshall, R D Allen.   

Abstract

In lethally irradiated normal mice reconstituted with both normal and autoimmune mutant viable motheaten (mev) bone marrow, the mev-derived B and T cells display aberrant behavior, while those derived from the normal bone marrow develop and function normally. The observed developmental abnormalities of mev B and T lymphocytes are therefore intrinsic to these cell types, rather than being determined by defective influences from the cells' environment. These data bring into question the in vivo significance of reported intercellular regulatory defects in motheaten (me) and mev mice and suggest that these mutations affect a gene whose product acts cell autonomously in the development of several hematopoietic cell lineages including B and T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668962      PMCID: PMC297821          DOI: 10.1073/pnas.86.16.6279

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

2.  Absence of thymus in a mouse mutant.

Authors:  E M Pantelouris
Journal:  Nature       Date:  1968-01-27       Impact factor: 49.962

3.  'Nude', a new hairless gene with pleiotropic effects in the mouse.

Authors:  S P Flanagan
Journal:  Genet Res       Date:  1966-12       Impact factor: 1.588

4.  Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins.

Authors:  L D Shultz; M C Green
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

5.  Rearrangement and expression of endogenous immunoglobulin genes occur in many murine B cells expressing transgenic membrane IgM.

Authors:  A M Stall; F G Kroese; F T Gadus; D G Sieckmann; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro.

Authors:  E S Medlock; I Goldschneider; D L Greiner; L Shultz
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

7.  Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology.

Authors:  M C Green; L D Shultz
Journal:  J Hered       Date:  1975 Sep-Oct       Impact factor: 2.645

8.  Lymphohemopoiesis in culture is prevented by interaction with adherent bone marrow cells from mutant viable motheaten mice.

Authors:  S Hayashi; P L Witte; L D Shultz; P W Kincade
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

9.  Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice.

Authors:  C J Painter; M Monestier; A Chew; A Bona-Dimitriu; K Kasturi; C Bailey; V E Scott; C L Sidman; C A Bona
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Isolation of antigen-binding cells from unprimed mice: demonstration of antibody-forming cell precursor activity and correlation between precursor and secreted antibody avidities.

Authors:  M H Julius; L A Herzenberg
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  4 in total

1.  Adoptive transfer of viable motheaten humoral autoimmunity in cyclophosphamide-immunodepressed beige recipient mice.

Authors:  L Kuntz; D Velin; F Pflumio; F Loor
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

2.  Increased expression of the stefin A cysteine proteinase inhibitor occurs in the myelomonocytic cell-infiltrated tissues of autoimmune motheaten mice.

Authors:  I Mlinaric-Rascan; S L Asa; K A Siminovitch
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

Review 3.  Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.

Authors:  Yadhu Sharma; Samina Bashir; Puja Bhardwaj; Altaf Ahmad; Farah Khan
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

4.  Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice.

Authors:  M Kozlowski; I Mlinaric-Rascan; G S Feng; R Shen; T Pawson; K A Siminovitch
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.